CN102178862B - 香连消毒液的制备及质量检测方法 - Google Patents
香连消毒液的制备及质量检测方法 Download PDFInfo
- Publication number
- CN102178862B CN102178862B CN 201110105898 CN201110105898A CN102178862B CN 102178862 B CN102178862 B CN 102178862B CN 201110105898 CN201110105898 CN 201110105898 CN 201110105898 A CN201110105898 A CN 201110105898A CN 102178862 B CN102178862 B CN 102178862B
- Authority
- CN
- China
- Prior art keywords
- solution
- connects
- fragrant
- disinfectant solution
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000645 desinfectant Substances 0.000 title claims abstract description 104
- 238000002360 preparation method Methods 0.000 title claims abstract description 26
- 238000001514 detection method Methods 0.000 title claims abstract description 6
- 239000000203 mixture Substances 0.000 claims abstract description 21
- 230000002147 killing effect Effects 0.000 claims abstract description 12
- 241000700605 Viruses Species 0.000 claims abstract description 7
- 241000233866 Fungi Species 0.000 claims abstract description 5
- 239000007924 injection Substances 0.000 claims abstract description 3
- 238000002347 injection Methods 0.000 claims abstract description 3
- 239000000243 solution Substances 0.000 claims description 163
- 238000012360 testing method Methods 0.000 claims description 57
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 46
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 36
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 32
- 239000013558 reference substance Substances 0.000 claims description 31
- 239000007788 liquid Substances 0.000 claims description 28
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 27
- 239000002304 perfume Substances 0.000 claims description 24
- 238000000034 method Methods 0.000 claims description 23
- 238000000605 extraction Methods 0.000 claims description 22
- 235000013599 spices Nutrition 0.000 claims description 21
- 239000003814 drug Substances 0.000 claims description 19
- 239000003208 petroleum Substances 0.000 claims description 18
- 238000003756 stirring Methods 0.000 claims description 18
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 16
- VKJGBAJNNALVAV-UHFFFAOYSA-M Berberine chloride (TN) Chemical compound [Cl-].C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 VKJGBAJNNALVAV-UHFFFAOYSA-M 0.000 claims description 15
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 15
- 239000000463 material Substances 0.000 claims description 14
- 239000006228 supernatant Substances 0.000 claims description 14
- 240000004784 Cymbopogon citratus Species 0.000 claims description 12
- 235000017897 Cymbopogon citratus Nutrition 0.000 claims description 12
- 238000012856 packing Methods 0.000 claims description 12
- 239000000341 volatile oil Substances 0.000 claims description 12
- 230000000844 anti-bacterial effect Effects 0.000 claims description 11
- 239000000706 filtrate Substances 0.000 claims description 11
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 10
- 238000010790 dilution Methods 0.000 claims description 10
- 239000012895 dilution Substances 0.000 claims description 10
- 239000008213 purified water Substances 0.000 claims description 10
- 230000008569 process Effects 0.000 claims description 9
- 239000007921 spray Substances 0.000 claims description 9
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 8
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 8
- 238000009835 boiling Methods 0.000 claims description 8
- 238000004821 distillation Methods 0.000 claims description 8
- 239000000741 silica gel Substances 0.000 claims description 8
- 229910002027 silica gel Inorganic materials 0.000 claims description 8
- 239000002904 solvent Substances 0.000 claims description 8
- 238000004809 thin layer chromatography Methods 0.000 claims description 8
- 241000628997 Flos Species 0.000 claims description 7
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 7
- 229920000053 polysorbate 80 Polymers 0.000 claims description 7
- UILPJVPSNHJFIK-UHFFFAOYSA-N Paeonol Chemical compound COC1=CC=C(C(C)=O)C(O)=C1 UILPJVPSNHJFIK-UHFFFAOYSA-N 0.000 claims description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 6
- 230000006837 decompression Effects 0.000 claims description 6
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 claims description 6
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 5
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims description 5
- 235000019796 monopotassium phosphate Nutrition 0.000 claims description 5
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 claims description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 4
- 238000003556 assay Methods 0.000 claims description 4
- 229940079593 drug Drugs 0.000 claims description 4
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 claims description 4
- 238000007689 inspection Methods 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 239000003921 oil Substances 0.000 claims description 4
- 239000012085 test solution Substances 0.000 claims description 4
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 claims description 4
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 claims description 4
- 235000012141 vanillin Nutrition 0.000 claims description 4
- 238000005303 weighing Methods 0.000 claims description 4
- ZSBXGIUJOOQZMP-UHFFFAOYSA-N Isomatrine Natural products C1CCC2CN3C(=O)CCCC3C3C2N1CCC3 ZSBXGIUJOOQZMP-UHFFFAOYSA-N 0.000 claims description 3
- ZSBXGIUJOOQZMP-JLNYLFASSA-N Matrine Chemical compound C1CC[C@H]2CN3C(=O)CCC[C@@H]3[C@@H]3[C@H]2N1CCC3 ZSBXGIUJOOQZMP-JLNYLFASSA-N 0.000 claims description 3
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 3
- 239000004141 Sodium laurylsulphate Substances 0.000 claims description 3
- 239000005844 Thymol Substances 0.000 claims description 3
- 230000002159 abnormal effect Effects 0.000 claims description 3
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims description 3
- 239000003480 eluent Substances 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- YLTGFGDODHXMFB-UHFFFAOYSA-N isoacetovanillon Natural products COC1=CC=C(C(C)=O)C=C1O YLTGFGDODHXMFB-UHFFFAOYSA-N 0.000 claims description 3
- 229930014456 matrine Natural products 0.000 claims description 3
- 239000012982 microporous membrane Substances 0.000 claims description 3
- 230000007935 neutral effect Effects 0.000 claims description 3
- MLIBGOFSXXWRIY-UHFFFAOYSA-N paeonol Natural products COC1=CC=C(O)C(C(C)=O)=C1 MLIBGOFSXXWRIY-UHFFFAOYSA-N 0.000 claims description 3
- 230000001105 regulatory effect Effects 0.000 claims description 3
- 235000019333 sodium laurylsulphate Nutrition 0.000 claims description 3
- 229960000790 thymol Drugs 0.000 claims description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 2
- NNDXJNAEVHGCFK-UHFFFAOYSA-M C(C)O.N(=O)[O-].[Na+] Chemical compound C(C)O.N(=O)[O-].[Na+] NNDXJNAEVHGCFK-UHFFFAOYSA-M 0.000 claims description 2
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 claims description 2
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 claims description 2
- 239000005770 Eugenol Substances 0.000 claims description 2
- 229910021578 Iron(III) chloride Inorganic materials 0.000 claims description 2
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 claims description 2
- 235000007212 Verbena X moechina Moldenke Nutrition 0.000 claims description 2
- 240000001519 Verbena officinalis Species 0.000 claims description 2
- 235000001594 Verbena polystachya Kunth Nutrition 0.000 claims description 2
- 235000007200 Verbena x perriana Moldenke Nutrition 0.000 claims description 2
- 235000002270 Verbena x stuprosa Moldenke Nutrition 0.000 claims description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- 239000000853 adhesive Substances 0.000 claims description 2
- 230000001070 adhesive effect Effects 0.000 claims description 2
- 230000001476 alcoholic effect Effects 0.000 claims description 2
- ONBIUAZBGHXJDM-UHFFFAOYSA-J bismuth;potassium;tetraiodide Chemical compound [K+].[I-].[I-].[I-].[I-].[Bi+3] ONBIUAZBGHXJDM-UHFFFAOYSA-J 0.000 claims description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 2
- XEKOWRVHYACXOJ-UHFFFAOYSA-N ethyl acetate Substances CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 2
- 229960002217 eugenol Drugs 0.000 claims description 2
- 239000000945 filler Substances 0.000 claims description 2
- 239000003205 fragrance Substances 0.000 claims description 2
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 claims description 2
- 238000004811 liquid chromatography Methods 0.000 claims description 2
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical compound CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 claims description 2
- 239000000377 silicon dioxide Substances 0.000 claims description 2
- 230000035943 smell Effects 0.000 claims description 2
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 2
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 2
- 238000011003 system suitability test Methods 0.000 claims description 2
- 229940098465 tincture Drugs 0.000 claims description 2
- 239000000273 veterinary drug Substances 0.000 claims description 2
- 241000894006 Bacteria Species 0.000 abstract description 10
- 230000000694 effects Effects 0.000 abstract description 9
- 230000002401 inhibitory effect Effects 0.000 abstract description 5
- 231100000331 toxic Toxicity 0.000 abstract description 4
- 230000002588 toxic effect Effects 0.000 abstract description 4
- 230000008901 benefit Effects 0.000 abstract description 2
- 238000005507 spraying Methods 0.000 abstract description 2
- 241001233914 Chelidonium majus Species 0.000 abstract 1
- 244000247747 Coptis groenlandica Species 0.000 abstract 1
- 235000002991 Coptis groenlandica Nutrition 0.000 abstract 1
- FEPOUSPSESUQPD-UHFFFAOYSA-N Cymbopogon Natural products C1CC2(C)C(C)C(=O)CCC2C2(C)C1C1(C)CCC3(C)CCC(C)C(C)C3C1(C)CC2 FEPOUSPSESUQPD-UHFFFAOYSA-N 0.000 abstract 1
- 241000931332 Cymbopogon Species 0.000 abstract 1
- 244000245214 Mentha canadensis Species 0.000 abstract 1
- 235000001878 Mentha haplocalyx Nutrition 0.000 abstract 1
- 241000717679 Mosla Species 0.000 abstract 1
- 244000223014 Syzygium aromaticum Species 0.000 abstract 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 abstract 1
- 150000001860 citric acid derivatives Chemical class 0.000 abstract 1
- 230000007547 defect Effects 0.000 abstract 1
- 230000000249 desinfective effect Effects 0.000 abstract 1
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 15
- 239000000523 sample Substances 0.000 description 15
- 241000711404 Avian avulavirus 1 Species 0.000 description 9
- 241000191967 Staphylococcus aureus Species 0.000 description 9
- 241000287828 Gallus gallus Species 0.000 description 8
- 210000001161 mammalian embryo Anatomy 0.000 description 8
- 241000588724 Escherichia coli Species 0.000 description 7
- 238000005516 engineering process Methods 0.000 description 7
- 239000013642 negative control Substances 0.000 description 7
- 230000001954 sterilising effect Effects 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 238000004659 sterilization and disinfection Methods 0.000 description 5
- 230000000638 stimulation Effects 0.000 description 5
- 241000193755 Bacillus cereus Species 0.000 description 4
- 238000004500 asepsis Methods 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 239000008363 phosphate buffer Substances 0.000 description 4
- 239000013641 positive control Substances 0.000 description 4
- 206010015150 Erythema Diseases 0.000 description 3
- 206010040880 Skin irritation Diseases 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 241000194017 Streptococcus Species 0.000 description 3
- 230000003385 bacteriostatic effect Effects 0.000 description 3
- 238000011081 inoculation Methods 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 231100000475 skin irritation Toxicity 0.000 description 3
- 230000036556 skin irritation Effects 0.000 description 3
- 239000011550 stock solution Substances 0.000 description 3
- 241000222122 Candida albicans Species 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 2
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 description 2
- 208000005374 Poisoning Diseases 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 241000385540 bacterium 10 Species 0.000 description 2
- YBHILYKTIRIUTE-UHFFFAOYSA-N berberine Chemical compound C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 YBHILYKTIRIUTE-UHFFFAOYSA-N 0.000 description 2
- 229940093265 berberine Drugs 0.000 description 2
- QISXPYZVZJBNDM-UHFFFAOYSA-N berberine Natural products COc1ccc2C=C3N(Cc2c1OC)C=Cc4cc5OCOc5cc34 QISXPYZVZJBNDM-UHFFFAOYSA-N 0.000 description 2
- 229940095731 candida albicans Drugs 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 231100000021 irritant Toxicity 0.000 description 2
- 239000002085 irritant Substances 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 244000000010 microbial pathogen Species 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 230000017074 necrotic cell death Effects 0.000 description 2
- 231100000572 poisoning Toxicity 0.000 description 2
- 230000000607 poisoning effect Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010012434 Dermatitis allergic Diseases 0.000 description 1
- 208000009701 Embryo Loss Diseases 0.000 description 1
- 206010015946 Eye irritation Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 206010037423 Pulmonary oedema Diseases 0.000 description 1
- 231100000645 Reed–Muench method Toxicity 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 231100000460 acute oral toxicity Toxicity 0.000 description 1
- 231100000570 acute poisoning Toxicity 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 208000035269 cancer or benign tumor Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000003559 chemosterilizing effect Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 206010014801 endophthalmitis Diseases 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 231100000013 eye irritation Toxicity 0.000 description 1
- 210000004709 eyebrow Anatomy 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 231100000025 genetic toxicology Toxicity 0.000 description 1
- 230000001738 genotoxic effect Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 206010023683 lagophthalmos Diseases 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 231100001254 ocular irritant Toxicity 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 208000005333 pulmonary edema Diseases 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 238000005464 sample preparation method Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000011218 seed culture Methods 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 239000003206 sterilizing agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000012422 test repetition Methods 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 238000009602 toxicology test Methods 0.000 description 1
Images
Landscapes
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110105898 CN102178862B (zh) | 2011-04-27 | 2011-04-27 | 香连消毒液的制备及质量检测方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110105898 CN102178862B (zh) | 2011-04-27 | 2011-04-27 | 香连消毒液的制备及质量检测方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102178862A CN102178862A (zh) | 2011-09-14 |
CN102178862B true CN102178862B (zh) | 2012-12-26 |
Family
ID=44565268
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201110105898 Active CN102178862B (zh) | 2011-04-27 | 2011-04-27 | 香连消毒液的制备及质量检测方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102178862B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104397077A (zh) * | 2014-11-26 | 2015-03-11 | 成都顺发消洗科技有限公司 | 新型灭菌液 |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102835424A (zh) * | 2012-09-25 | 2012-12-26 | 上海海洋大学 | 一种水产养殖用水体消毒剂及其使用方法 |
CN103584256B (zh) * | 2013-11-26 | 2015-07-22 | 青岛嘉瑞生物技术有限公司 | 一种利用石莼资源化开发的天然食品保鲜剂及制备方法 |
CN103814967B (zh) * | 2014-03-03 | 2016-05-11 | 北京生泰尔科技股份有限公司 | 一种水产消毒用的中草药颗粒制剂及其制备方法 |
CN104430575B (zh) * | 2014-09-01 | 2018-07-06 | 李晔 | 用于病房内消毒的消毒液及制法 |
CN104782672A (zh) * | 2015-03-25 | 2015-07-22 | 申爱华 | 一种用于清洗尿液分析仪的消毒液及其制备方法 |
CN104940767B (zh) * | 2015-07-14 | 2018-11-02 | 张军 | 抗病原微生物的中药组合物及其制备方法和应用 |
CN105851086A (zh) * | 2016-04-29 | 2016-08-17 | 广西中医药大学 | 一种通过空气发挥抑菌固本功效的瑶药组合提取物 |
CN105901036A (zh) * | 2016-04-29 | 2016-08-31 | 广西中医药大学 | 一种通过空气发挥抑菌安眠功效的瑶药组合提取物 |
CN106091124A (zh) * | 2016-07-27 | 2016-11-09 | 赣州安宏环保科技有限公司 | 消除空气污染的空调装置 |
CN106332922A (zh) * | 2016-08-23 | 2017-01-18 | 泉州万利得节能科技有限公司 | 一种天然空气清新剂及其制备方法 |
CN106359291A (zh) * | 2016-09-24 | 2017-02-01 | 王德 | 一种土鸡的快速孵化方法 |
CN106852347A (zh) * | 2016-12-12 | 2017-06-16 | 钦州学院 | 一种香连消毒液及其制备方法 |
CN106614376A (zh) * | 2016-12-31 | 2017-05-10 | 枞阳县恒祥生态农业有限公司 | 一种雏鸡白痢病的防治方法 |
CN107916574A (zh) * | 2017-10-31 | 2018-04-17 | 南宁市致良行文化传播有限公司 | 一种孔雀羽毛的处理方法 |
CN111249346A (zh) * | 2020-03-13 | 2020-06-09 | 河南华牧生物科技有限公司 | 治疗仔猪腹泻的复方牛至口服液的制备及使用方法 |
CN111714591A (zh) * | 2020-06-11 | 2020-09-29 | 山东维雅诺生物科技有限公司 | 一种消毒喷雾剂及其制备方法 |
CN113368193B (zh) * | 2021-06-09 | 2022-10-04 | 海而思(郑州)科技有限公司 | 一种皮肤抑菌凝胶及其制备方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101518569B (zh) * | 2009-03-30 | 2011-10-05 | 士轲兴 | 一种含牛至油的人用消毒液及其生产方法 |
-
2011
- 2011-04-27 CN CN 201110105898 patent/CN102178862B/zh active Active
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104397077A (zh) * | 2014-11-26 | 2015-03-11 | 成都顺发消洗科技有限公司 | 新型灭菌液 |
Also Published As
Publication number | Publication date |
---|---|
CN102178862A (zh) | 2011-09-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102178862B (zh) | 香连消毒液的制备及质量检测方法 | |
CN1883275B (zh) | 一种植物抗生素及其应用 | |
Xu et al. | Antiviral activity and mode of action of extracts from neem seed kernel against duck plague virus in vitro | |
CN101357146B (zh) | 山蜡梅有效部位群的制备方法及其制剂的制法与用途 | |
CN113440563B (zh) | 一种复方鱼腥草喷雾剂及其制备方法和应用 | |
CN112205430B (zh) | 一种中药提取物组合物及其制备方法与应用 | |
CN108041104A (zh) | 一种检验科用中药复合型消毒液及其制备方法 | |
CN113768984A (zh) | 一种中药组合物及其制备方法和应用 | |
CN101732632B (zh) | 一种肤疾洗剂组合物及制备方法 | |
CN101322746B (zh) | 二次发酵法天然药物制剂、制备方法及用途 | |
CN108690724A (zh) | 一种通城虎挥发油在制备防治癌症和/抑菌产品中的应用 | |
CN106706626A (zh) | 一种岩生忍冬成分鉴定及抗菌活性评价方法 | |
CN102397333A (zh) | 一种银黄注射液的制备及质量检测方法 | |
CN101612204A (zh) | 猪链球菌耐药抑制剂 | |
CN108653454A (zh) | 含刺黑珠的中药组合物在治疗猪传染性胸膜肺炎中的用途 | |
CN1739682A (zh) | 一种用于腔道的裸花紫珠软胶囊及其制备方法 | |
CN102188523B (zh) | 一种植物抗生素 | |
CN107998222A (zh) | 裸花紫珠提取物、其制备方法及应用 | |
CN108309972A (zh) | 广藿香酮在制备防治猪繁殖与呼吸综合征药物中的应用 | |
CN102240328B (zh) | 一种治疗感冒的中药及其制备方法 | |
Raju et al. | Phytochemical Analysis of Three Common Medicinal Plants (Gliricidia sepium, Melothria pendula, and Pithecellobium dulce) in the Philippines | |
CN109498741A (zh) | 一种用于润肺的药物组合物及其制备方法 | |
Ejimofor et al. | Determination of antimicrobial susceptibility pattern of bacteria isolated from herbal drugs hawked in Onitsha Anambra State Nigeria | |
CN108671088A (zh) | 一种畜禽养殖用中草药环保消毒剂及其制备方法和使用方法 | |
CN115607497B (zh) | 一种具有治疗白屑风功能的当归复方洗发液 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee | ||
CP01 | Change in the name or title of a patent holder |
Address after: 100081 room two, zone 12, 312 South Main Street, Haidian District, Beijing, Zhongguancun Patentee after: BEIJING CENTRE BIOLOGY CO., LTD. Address before: 100081 room two, zone 12, 312 South Main Street, Haidian District, Beijing, Zhongguancun Patentee before: Beijing Centre Biology Co., Ltd. |
|
CP02 | Change in the address of a patent holder | ||
CP02 | Change in the address of a patent holder |
Address after: 102600 No.44 Yongda Road, Daxing biomedical industrial base, Zhongguancun Science and Technology Park, Daxing District, Beijing Patentee after: BEIJING CENTRE BIOLOGY Co.,Ltd. Address before: 100081 room two, zone 12, 312 South Main Street, Haidian District, Beijing, Zhongguancun Patentee before: BEIJING CENTRE BIOLOGY Co.,Ltd. |
|
DD01 | Delivery of document by public notice | ||
DD01 | Delivery of document by public notice |
Addressee: Lu Fengqi Document name: Notification of conformity |